Damora Therapeutics, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The company's lead product includes DMR-001, a investigational monoclonal antibody therapy that targets mutations in CALR, for the treatment of essential thrombocythemia; and DMR-002 and DMR-003, both anti-mutCALR-based therapies, with the intent to ultimately address the full spectrum of mutCALR MPN patients. It also develops GB3226, a small molecule inhibitor of ENL-YEATS and FLT3 for the treatment of acute myeloid leukemia. Damora Therapeutics, Inc. was founded in 2011 and is headquartered in Waltham, Massachusetts.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| FidelityFMR | fundamental | 9.05M | $234.28M | 0.01% | Added+3686.7% | 2026-03-31 |
| Viking | long/short | 2.31M | $59.86M | 0.17% | New | 2026-03-31 |
| Citadel | multi-strat | 1.19M | $30.92M | 0.04% | Added+995.1% | 2026-03-31 |
| Wellington | fundamental | 1.06M | $27.40M | 0.01% | New | 2026-03-31 |
| StateStreet | passive | 183.9K | $4.76M | 0.00% | New | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2025-03-19 | -2.82 | -5.00 | -77.30% |
| 2024-11-01 | -3.70 | -3.39 | +8.38% |
| 2024-08-12 | -6.00 | -5.00 | +16.67% |
| 2024-04-29 | -4.25 | -5.00 | -17.65% |
| 2024-03-08 | -6.25 | -4.76 | +23.80% |
| 2023-11-06 | -12.12 | -4.99 | +58.87% |
| 2023-07-31 | -14.67 | -10.25 | +30.11% |
| 2023-04-28 | -17.25 | -12.75 | +26.09% |
| 2023-03-09 | -14.25 | -13.75 | +3.51% |
| 2022-11-08 | -17.00 | -13.50 | +20.59% |
| 2022-07-29 | -17.25 | -16.75 | +2.90% |
| 2022-04-29 | -15.25 | -16.75 | -9.84% |
| 2022-02-17 | -14.00 | -13.25 | +5.36% |
| 2021-11-04 | -14.00 | -12.50 | +10.71% |
| 2021-08-05 | -13.50 | -12.25 | +9.26% |
| 2021-05-04 | -11.50 | -13.25 | -15.22% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| DMRA | -1.89% | -11.40% | +8.13% | +710.42% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | -4.86% | -6.76% | +11.57% | +697.73% |